Mayu Ukai

821 total citations
45 papers, 607 citations indexed

About

Mayu Ukai is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Mayu Ukai has authored 45 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 9 papers in Obstetrics and Gynecology. Recurrent topics in Mayu Ukai's work include Neuropeptides and Animal Physiology (18 papers), Receptor Mechanisms and Signaling (15 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Mayu Ukai is often cited by papers focused on Neuropeptides and Animal Physiology (18 papers), Receptor Mechanisms and Signaling (15 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Mayu Ukai collaborates with scholars based in Japan, United States and Switzerland. Mayu Ukai's co-authors include Tsutomu Kameyama, S G Holtzman, T Kameyama, Masato Yoshihara, Yasuyuki Kishigami, Jiro Itoh, Hidenori Oguchi, Sho Tano, Michinori Mayama and Takayoshi Mamiya and has published in prestigious journals such as Annals of the New York Academy of Sciences, American Journal of Obstetrics and Gynecology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mayu Ukai

38 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayu Ukai Japan 16 344 290 101 86 82 45 607
A. Di Lieto Italy 12 186 0.5× 160 0.6× 55 0.5× 48 0.6× 11 0.1× 32 551
Machin Ian United Kingdom 4 83 0.2× 41 0.1× 78 0.8× 266 3.1× 26 0.3× 5 437
Janet Nooney United Kingdom 8 229 0.7× 213 0.7× 23 0.2× 33 0.4× 71 0.9× 11 405
Maureen Kelly United States 15 176 0.5× 99 0.3× 7 0.1× 42 0.5× 68 0.8× 23 557
Sherry Lu United States 12 252 0.7× 174 0.6× 30 0.3× 110 1.3× 47 0.6× 17 421
Sally J. Ratter United Kingdom 19 372 1.1× 226 0.8× 7 0.1× 141 1.6× 112 1.4× 25 916
Aili Guo Italy 12 107 0.3× 161 0.6× 10 0.1× 98 1.1× 114 1.4× 26 562
Y Yaoi Japan 12 42 0.1× 66 0.2× 89 0.9× 87 1.0× 15 0.2× 35 676
Yi T. Tseng United States 13 143 0.4× 121 0.4× 22 0.2× 42 0.5× 13 0.2× 20 338
Jorge Belmar Chile 14 150 0.4× 123 0.4× 5 0.0× 102 1.2× 62 0.8× 40 496

Countries citing papers authored by Mayu Ukai

Since Specialization
Citations

This map shows the geographic impact of Mayu Ukai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayu Ukai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayu Ukai more than expected).

Fields of papers citing papers by Mayu Ukai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayu Ukai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayu Ukai. The network helps show where Mayu Ukai may publish in the future.

Co-authorship network of co-authors of Mayu Ukai

This figure shows the co-authorship network connecting the top 25 collaborators of Mayu Ukai. A scholar is included among the top collaborators of Mayu Ukai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayu Ukai. Mayu Ukai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshihara, Masato, Kaoru Kitamura, Michinori Mayama, et al.. (2022). Factors associated with response to compression-based physical therapy for secondary lower limb lymphedema after gynecologic cancer treatment: a multicenter retrospective study. BMC Cancer. 22(1). 25–25. 1 indexed citations
2.
Ukai, Mayu, Shiro Suzuki, Masato Yoshihara, et al.. (2021). Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary?. International Journal of Clinical Oncology. 27(3). 609–618. 2 indexed citations
3.
Tano, Sho, Michinori Mayama, Kaname Uno, et al.. (2021). Relationship between vaginal group B streptococcus colonization in the early stage of pregnancy and preterm birth: a retrospective cohort study. BMC Pregnancy and Childbirth. 21(1). 141–141. 15 indexed citations
4.
Shimizu, Yusuke, et al.. (2021). The Prognostic Significance of Peritumoral Lymphocytes’ Band-like Structure in Type II Endometrial Cancer. Anticancer Research. 41(1). 249–258. 3 indexed citations
5.
Mouri, Akihiro, Mayu Ukai, Sho Hasegawa, et al.. (2018). Juvenile social defeat stress exposure persistently impairs social behaviors and neurogenesis. Neuropharmacology. 133. 23–37. 51 indexed citations
6.
Mayama, Michinori, Masato Yoshihara, Kaname Uno, et al.. (2016). Factors influencing brain natriuretic peptide levels in healthy pregnant women. International Journal of Cardiology. 228. 749–753. 23 indexed citations
7.
Uno, Kaname, Sho Tano, Masato Yoshihara, et al.. (2016). A Case Report and Literature Review of Spontaneous Perforation of Pyometra. Journal of Emergency Medicine. 50(5). e231–e236. 17 indexed citations
8.
Yoshihara, Masato, Kaname Uno, Sho Tano, et al.. (2015). The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study. Critical Care. 19(1). 369–369. 26 indexed citations
9.
Ukai, Mayu, et al.. (2005). Involvement of dopamine D3 and D4 receptors in the discriminativestimulus properties of cocaine in the rat. Methods and Findings in Experimental and Clinical Pharmacology. 27(9). 645–645. 9 indexed citations
10.
Mamiya, Takayoshi, T Matsumura, & Mayu Ukai. (2004). Effects of L‐745,870, a Dopamine D4 Receptor Antagonist, on Naloxone‐Induced Morphine Dependence in Mice. Annals of the New York Academy of Sciences. 1025(1). 424–429. 20 indexed citations
11.
Ukai, Mayu, Masahiko Suzuki, & Takayoshi Mamiya. (2002). Effects of U-50,488H, a κ-opioid receptor agonist, on the learned helplessness model of depression in mice. Journal of Neural Transmission. 109(9). 1221–1225. 21 indexed citations
12.
Mamiya, Takayoshi, Yukihiro Noda, Xiuhai Ren, et al.. (2001). Morphine tolerance and dependence in the nociceptin receptor knockout mice. Journal of Neural Transmission. 108(12). 1349–1361. 34 indexed citations
13.
Ukai, Mayu. (2000). [Influence of stress on learning and memory].. PubMed. 20(3). 93–6. 1 indexed citations
14.
Kameyama, Tsutomu, Mayu Ukai, & Norihiro Shinkai. (1998). Ameliorative effects of tachykinins on scopolamine-inducedimpairment of spontaneous alternation performance in mice. Methods and Findings in Experimental and Clinical Pharmacology. 20(7). 555–555. 23 indexed citations
15.
Kameyama, Tsutomu, et al.. (1994). Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice. Neuropharmacology. 33(10). 1167–1169. 9 indexed citations
16.
Ukai, Mayu, et al.. (1994). Differential modulation of behavioral responses by [D-Ala2, NMePhe4, Gly-ol]enkephalin, [D-Ala2] deltorphin II and [D-Pen2, L-Pen5]enkephalin in the mouse.. PubMed. 14(3). 161–8. 1 indexed citations
17.
Ukai, Mayu, et al.. (1992). Systemic administration of dynorphin A(1–13) markedly inhibits different behavioural responses induced by cocaine in the mouse. Neuropharmacology. 31(9). 843–849. 12 indexed citations
18.
Ukai, Mayu, Tohru Toyoshi, & Tsutomu Kameyama. (1989). Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (d-Ala2-d-Leu5-enkephalin) and DPLPE (d-Pen2-l-Pen5-enkephalin). Neuropharmacology. 28(10). 1033–1039. 21 indexed citations
19.
Ukai, Mayu, et al.. (1988). The opioid antagonist, MR2266, specifically decreases saline intake in the mouse. Neuropharmacology. 27(10). 1027–1031. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Di Lieto Breakdown of academic impact, for papers by Machin Ian Breakdown of academic impact, for papers by Janet Nooney Breakdown of academic impact, for papers by Maureen Kelly Breakdown of academic impact, for papers by Sherry Lu Breakdown of academic impact, for papers by Sally J. Ratter Breakdown of academic impact, for papers by Aili Guo Breakdown of academic impact, for papers by Y Yaoi Breakdown of academic impact, for papers by Yi T. Tseng Breakdown of academic impact, for papers by Jorge Belmar
Rankless by CCL
2026